The incidence of Type 2 Diabetes (T2D) complications such as CV disease and nephropathy continue to rise in Malaysia. In fact, more of such cases have been recorded early in the primary care setting. More worryingly, heart failure is another fatal, frequent complications that could occur early in T2D patients but is often missed and forgotten. Prevention of these complications remain a formidable challenge since patients are still not receiving optimal treatment early and medications providing benefits beyond glucose-lowering are not prioritized.
Primary care setting is where majority of T2D patients are being managed. It is therefore paramount that a shift of mindset should take place starting at this level whereby the management of T2D should no longer be purely glucosecentric focus. Given their important role, primary care physicians (PCPs) should now consider a more holistic approach that addresses and prevents early cardiorenal risks in addition to usual glucose-lowering therapy.
ACTing on the Evidence digital education program for PCPs intends to be at the forefront for this early paradigm shift. This program is developed as three modules to collectively address the early yet alarming burden of cardiorenal complications in T2D and how SGLT2i inhibitors in light of growing evidence can address those problems. After completing this program, it is with hope that PCPs would be confident and more proactive in diagnosing and treating the disease early and appropriately in order to prevent cardiorenal complications in T2D patients.
Learning Objectives
To discuss why renal protection is important in diabetes management
To review the proven renal therapies in diabetes prior to SGLT2i
To outline the evidence for the renal benefits of SGLT2i in diabetes
This ACT Module 2 is presented by Dr. Chow Yok Wai (Consultant Nephrologist and Physician in Pantai, Hospital Ayer Keroh, Melaka, Malaysia and Senior lecturer to the International Medical University, Malaysia).
This CPD activity is supported by an educational grant from Astra Zeneca.
Approval Code: MY_Diab_MY-4413_23/12/2019

There are 8 modules in this course. Participants must successfully complete all 8 modules to obtain 1 CPD point, that will be credited instantly in your MMA CPD account.